All strategic inquiries
Beyond inquiries into specific complaints about maladministration in the EU institutions, the European Ombudsman also has the power to proactively work on broader strategic issues. The Ombudsman carries out strategic investigations on her own initiative, which aim to draw attention to matters of public interest and look into wider systemic issues affecting the EU institutions and the democratic decision-making process.
Showing 1 - 10 of 64 results
How the European Centre for Disease Prevention and Control gathered and assessed information during the COVID-19 crisis
Strategic Inquiry OI/3/2020/TE - Tuesday | 09 February 2021
In the context of wider strategic work on the response of the EU administration during the COVID-19 crisis, the Ombudsman has also been examining the work of the European Centre for Disease Prevention and Control (ECDC). This included a particular focus on how the ECDC has been gathering and assessing the data that underpins its work. The Ombudsman's inquiry highlighted shortcomings in how the dat...
Strategic Inquiry OI/1/2021/KR - Friday | 05 February 2021
As a follow-up to her previous inquiry on how the European Commission manages ‘revolving doors’, the Ombudsman has launched an own-initiative inquiry into how the Commission handles revolving doors situations of staff members who apply for unpaid leave to take up an outside activity and (senior) managers who apply for approval to take up an activity after leaving the Commission. The inquiry aims t...
Strategic inquiry OI/2/2021/MMO into how the European Commission monitors EU Funds used to promote the right of persons with disabilities and older persons to independent living
Strategic Inquiry OI/2/2021/MMO - Friday | 05 February 2021
The Ombudsman opened an own-initiative inquiry to look into how the European Commission monitors that European Structural and Investment (ESI) Funds are used to promote the right of persons with disabilities and older persons to independent living. As a signatory of the UN Convention on the Rights of Persons with Disabilities (UN CRPD), the EU is committed to promoting the right to independent liv...
How the European Border and Coast Guard Agency (Frontex) deals with complaints about alleged fundamental rights breaches through its 'Complaints Mechanism'
Strategic Inquiry OI/5/2020/MHZ - Thursday | 04 February 2021
The Ombudsman opened an inquiry on her own initiative into the European Border and Coast Guard Agency's (Frontex) Complaints Mechanism for those who believe their fundamental rights have been breached in the context of a Frontex operation. The Ombudsman sent a series of questions to Frontex, relating to the effectiveness and transparency of the Complaints Mechanism, and the role of the 'fundamenta...
Strategic Inquiry OI/4/2020/TE - Wednesday | 13 January 2021
In the context of wider strategic work on the response of the EU administration during the COVID-19 crisis, the Ombudsman has also been examining the work of the Council of the EU, notably as regards the transparency of its decision making. In particular, the Ombudsman has assessed the decision by the Council to derogate, temporarily, from its Rules of Procedure during the crisis, and the implicat...
Strategic Inquiry OI/1/2019/MIG - Thursday | 05 December 2019
2 December 2019 - Euro area Member States have improved public access to decision making following a request by the Ombudsman to Eurogroup President Mário Centeno. Under the changes, the draft agendas of the Eurogroup meetings will be published earlier in advance than previously and the letter summarising the meetings will be more detailed. Also, the dates of the Euro Working Group meetings will b...
Strategic Inquiry OI/1/2019/MIG - Monday | 13 May 2019
Transparency of the bodies involved in preparing Eurogroup meetings.
Own-initiative inquiry into the EC's alleged failure to reply to correspondence concerning an order of reimbursement
Strategic Inquiry OI/7/2018/JF - Wednesday | 28 November 2018
Strategic Inquiry OI/2/2016/RH - Thursday | 20 July 2017
The Ombudsman in February opened a strategic inquiry into the delay in the European Commission's handling of over 200 proposals to test chemicals to determine potential harm to human reproductive health. The inquiry aims to find out what the Commission is doing to ensure that decisions on these files are taken as quickly as possible. The Ombudsman has asked for a response by 31 May 2016.
Strategic Inquiry OI/7/2017/KR - Monday | 17 July 2017
26 November 2019 - An Ombudsman inquiry into how the European Medicines Agency (EMA) engages with pharma companies before they apply for market access for their medicines has led to several measures to improve the transparency and objectivity of the process. Working constructively with the Ombudsman, EMA has agreed to introduce a log of the scientific advice concerning medicines in the market appr...